On Thursday, Pressure BioSciences, Inc. (OTCQB: PBIO) announced that it has received the award for ‘Best New Instrument For Sample Preparation 2017’ from Corporate America News (http://nnw.fm/D04Mx) for its Barocycler 2320Extreme.
The unit is the most recent product added to PBIO’s Barocycler line. It is a smaller device designed for preparing protein samples for review. It is sold to the life science market, which is valued at roughly $6 billion, according to industry data.
Pressure BioSciences, Inc. develops and sells laboratory instrumentation. It manufactures products in static and alternating pressure. The company says it has installed more than 250 of its systems in 160 sites globally. While its focus is on forensics and biomarker discovery, its products are also utilized in vaccine manufacturing and drug discovery, design and histology.
The award was given to PBIO by Corporate America News as part of its 2017 North American Excellence Awards. Targeting the U.S. business market, the magazine has a circulation of some 135,000.
“We are honored to have been selected for this prestigious award,” Dr. Nate Lawrence, PBIO’s VP of marketing and sales, stated in a news release. “It was just eight months ago when we launched this next-generation Barocycler instrument, the EXT 2320. Since then, the instrument has been purchased by key scientists in academic, government, biotech and pharma labs worldwide, including institutions involved in the Cancer Moonshot Initiative. We believe this award affirms the significant potential of the Barocycler 2320.”
Richard T. Shumacher, president and CEO of PBIO, described in the magazine the specific features and benefits of the Barocycler 2320Extreme. He also discussed the history of the company and its future growth potential.
“In addition to our patented and cutting edge technology platform, we have both a hard-working, results-driven management and support team, and an experienced and supportive Board of Directors,” Shumacher said. “We believe that the combination of these factors will help ensure the success of our company with a concomitant strong return-on-investment for stakeholders in [PBIO].”
For more information, visit www.PressureBiosciences.com
About NetworkNewsWire
NetworkNewsWire (NNW) provides news aggregation and syndication, enhanced press release services and a full array of social communication solutions. As a multifaceted financial news and distribution company with an extensive team of journalists and writers, NNW is uniquely positioned to best serve private and public companies who need to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
For more information, visit https://www.NetworkNewsWire.com
Please see full disclaimers on the NetworkNewsWire website: http://nnw.fm/Disclaimer
No comments:
Post a Comment